The Positive Papers

1. New chemical wipes out 95% of termites without harming humans
   Researchers developed a compound that prevents drywood termites from forming new exoskeletons during their required molting stage. The treatment achieved roughly 95 percent colony mortality in controlled tests because termites cannot skip molting. It leaves humans and other non-target species unaffected since the mechanism is specific to insect cuticle development. The approach avoids the need for whole-structure fumigation that currently dominates termite control. Early results suggest the chemical could reach commercial use once field trials confirm long-term colony elimination rates. An open question is how quickly regulatory approval and distribution will scale the product beyond lab conditions. The work points to a lower-impact option for homeowners facing drywood termite pressure. The same life-cycle vulnerability could be explored for other insect pests that rely on periodic molting. Source: sciencedaily.com
2. A melanoma vaccine was hailed as a breakthrough. Which cancers are next?
   An mRNA-based melanoma vaccine demonstrated strong results in recent trials by training the immune system to recognize tumor-specific markers. The approach builds on the same platform used for other vaccines and has prompted researchers to test similar constructs against additional solid tumors. Early data indicate improved recurrence-free survival for melanoma patients receiving the vaccine alongside standard care. The next step is identifying which other cancers share enough predictable neoantigens for the same strategy to work. A remaining caveat is that efficacy must still be proven in larger, more diverse patient groups before broad adoption. The open question for the hosts is whether manufacturing capacity and trial enrollment can keep pace with promising early signals. The platform's flexibility means new versions could be designed once a tumor's neoantigen profile is sequenced. Regulatory pathways for these personalized constructs are still being clarified across different health authorities. Source: washingtonpost.com

Think Positive

Angela Duckworth describes grit as sustained passion and perseverance toward long-term goals even when progress feels slow. The termite research and vaccine work both illustrate how repeated small experiments compound into measurable results over years rather than weeks. Listeners can borrow the same stance by treating one daily action as a single rep in a longer sequence instead of expecting instant change. A concrete mental rep is to name the specific outcome you want from today’s effort, then complete the first physical step before checking results. This framing keeps motivation tied to identity rather than mood. The same persistence shows up when homeowners schedule an inspection they have been putting off or when patients ask their oncologist about trial options.

Do Positive Dispatch

If you signed up for your electricity provider’s time-of-use rate plan this week, reply to the club email with the exact rate difference you locked in and the first appliance you plan to shift.

Network pick: First Principles Daily (today): "A wedding venue can charge tens of thousands for one day when the building, food, and…"

Sources

https://www.sciencedaily.com/releases/2026/09/260919025248.htm https://www.washingtonpost.com/health/2026/09/19/melanoma-vaccine-was-hailed-breakthrough-which-cancers-are-next/

Do something about it.

💬 Reply to this email — Patrick reads every one.

Share: X · LinkedIn · WhatsApp

Forwarded this email? Subscribe here — it's free.